[Abstract]
Light chain systemic amyloidosis has low clinical incidence rate and
poor prognosis. Relevant diagnosis depends on the biopsy results, and
many patients were not confirmed until autopsy. Once amyloidosis is
suspected, it is necessary to communicate with their families on the
risks for treatment methods and prognosis.